H.I.G. Enters the CFMG Enterprise: What the 2013 Investment Proves—and What It Does Not
- Published
- Content last changed
- Public-evidence cutoff
- Sources checked
- Record through
- Editorial status
- Public-source editorial review complete
Core question. Did private-equity investment change the professional corporation's ownership, management, or both?
Evidence spine. H.I.G. announcement; 2012 MSA timing; later corporate records; missing stock evidence.
Evidence note. This article relies on public records and distinguishes established fact, party position, allegation, judicial finding, inference and unresolved question. Nothing here is a finding that any identified corporation or individual violated California law unless a cited adjudicative source expressly says so.
Opening frame#
H.I.G. Enters the CFMG Enterprise: What the 2013 Investment Proves—and What It Does Not is fundamentally an identity-and-continuity inquiry. The legal entity, the management platform, the public brand, and the county-facing operation may overlap without becoming interchangeable. The analysis therefore asks what changed, what persisted, and which primary records are capable of proving each proposition.
The governing question is narrow: Did private-equity investment change the professional corporation's ownership, management, or both? The article connects that question to juridical identity, operational integration, professional authority, ownership and succession, practical exit rights, and demonstrated veto power only where the evidence makes those connections material.
I. The Question and the Public Record#
The relevant public record is best read cumulatively. No single branding statement, county agenda item, corporate filing, bankruptcy disclosure, or management agreement resolves the entire relationship. The evidentiary value comes from comparing documents created for different purposes and asking whether they converge on the same allocation of identity, authority, economics, and professional responsibility.
What is not known#
No current primary record in the reviewed corpus establishes:
- who owns CFMG shares today;
- exact historical ownership percentages;
- whether Bazzel, Medrano, Kennedy, Herr, Fithian, or Taranath personally held shares at a particular time;
- whether Wellpath can nominate, approve, remove, or replace the physician owner;
- whether Wellpath holds a proxy, option, or forced-transfer right;
- whether CFMG can replace its MSO without ownership consequences.
The rule is locked:
Officer/director status is not shareholder status.
Very high confidence#
- CFMG is legally distinct from Wellpath LLC and WMI.
- CFMG remained active after Chapter 11.
- CFMG remains a County contractor and current labor-law employer in material California operations.
- Wellpath provides deep management infrastructure.
- The MSA formally reserves important professional functions to CFMG.
- Genuine physician leadership exists within CFMG.
- Wellpath enterprise quality/clinical infrastructure is substantive.
- Bankruptcy forced entity clarification and exposed integration.
- Public branding and corporate identity diverged enough to create real institutional confusion.
II. Structural and Historical Context#
From CFMG to the Wellpath Era: A California Corporate Timeline#
The modern CFMG–Wellpath structure is easier to understand when three histories are kept separate: the history of the California professional corporation, the history of the management enterprise around it, and the history of government contracts that continued through those changes.
A common mistake is to tell the story as a straight corporate succession:
CFMG → CMGC → Wellpath
The public documents do not support treating that shorthand as a complete legal genealogy.
A better model is three parallel tracks.
2019: the CFMG management agreement moves to Wellpath LLC#
The next public document is more precise.
Effective January 1, 2019, the parties executed an Assignment of Management Services Agreement.
The document identifies:
- California Forensic Medical Group, Inc. as the Company;
- Wellpath LLC as the Manager; and
- Wellpath Management, Inc., with its predecessor names, as the Outgoing Manager.
The assignment says the October 2018 corporate transaction made the entities affiliates and states that the MSA was being transferred to Wellpath LLC for efficiency in administering management functions. 2019 Assignment
That document is one of the clearest public markers of the transition into the Wellpath era.
It is also significant for another reason: the assignment states that the MSA was transferred together with related or incidental instruments, including relevant stock-transfer restriction agreements.
The assignment proves that such instruments were part of the transaction documents or related contractual architecture.
It does not reveal their operative terms.
That makes the underlying CFMG-specific stock-transfer and succession documents an important open-source target rather than a basis for speculation.
III. The Control and Governance Analysis#
The central thesis of this investigation#
The public record supports two propositions at the same time:
CFMG remains legally meaningful as a California professional corporation and public contractor.
and
Wellpath supplies a broad operating and management architecture around CFMG.
The next question is not whether those facts can coexist. They plainly can.
The next question is how authority moves through the system.
This series will trace that question across:
- corporate history;
- the management agreement;
- California corporate-practice law;
- county contracts;
- employment and HR systems;
- physician staffing;
- credentialing and privileging;
- medical records;
- utilization and referrals;
- clinical policy;
- finance and banking;
- insurance and claims;
- litigation positions;
- bankruptcy;
- and county-by-county operations.
Where the public record proves something, the investigation will say so.
Where it proves only an allegation, stipulation, company position, or administrative fact, that distinction will remain visible.
And where the public record does not establish who had the final authority, the answer will be open rather than inferred.
The 2012 MSA: professional corporation and management company#
One day before the calendar turned to 2013, CFMG entered a detailed Management Services Agreement with California Forensic Management Group, Inc., a Delaware corporation.
The contract describes two separate roles:
- CFMG as the California professional corporation providing medical services; and
- the management company as the provider of defined management and administrative services.
The agreement states that the entities are independent contractors and reserves professional medical services to CFMG. It also gives the management company a broad portfolio of administrative responsibilities. CFMG Management Services Agreement
This contract is the foundation for understanding the later Wellpath relationship.
Layer one: explicit professional independence#
The agreement begins with formal safeguards.
It describes the parties as independent contractors. It says CFMG is solely and exclusively in control of professional medical services and says the management company will not control the methods by which physicians practice medicine.
It also states that the manager will not provide a service that would itself constitute clinical practice or professional medical services.
Those provisions are substantial evidence of the intended legal allocation.
They should not be dismissed merely because the same contract contains extensive management powers.
At the same time, formal language is not proof of how every later decision actually operated.
That distinction — intended allocation versus actual practice — is the central theme of this investigation.
Pre-Wellpath foundation#
Early 1980s. CFMG develops as a California correctional-health provider. The historical corporation predates modern Wellpath branding by decades.
December 31, 2012. CFMG enters the Management Services Agreement that becomes the structural spine of the modern investigation. The MSA formally reserves professional medical authority to CFMG while granting a separate manager extensive exclusive administrative, financial, HR, records, IT, contracting, insurance, billing, compliance, and related functions.
January 2013. H.I.G. publicly announces a strategic investment in the enterprise associated with CFMG/CMGC. The public record supports private-equity entry at the enterprise level but does not, by itself, prove H.I.G. directly acquired CFMG physician shares.
Enterprise consolidation#
2015–2017. Raymond Herr, M.D. becomes publicly visible as CFMG President/CMO and authorized official. Litigation and County records later connect him to finance, contracts, staffing, policies, LVN scope, and mortality-review evidence.
October 1, 2018. H.I.G. combines Correct Care Solutions and its CMGC platform, creating the enterprise that becomes Wellpath. This is an enterprise combination; it does not establish that the California professional corporation merged out of existence.
January 1, 2019. The CFMG MSA and related/incidental instruments are assigned to Wellpath LLC. The assignment expressly references relevant stock-transfer restriction agreements. This is the strongest CFMG-specific proof that ownership/succession instruments existed, but not proof of their contents.
California Forensic Medical Group, Inc. (CFMG)#
The central California professional corporation. Current evidence strongly supports continuing legal existence, County-contract significance, employer identity in important labor/wage records, physician corporate governance, and litigation significance.
What is established:
- distinct juridical existence;
- professional-corporation status;
- continued current contracting/employer roles;
- physician officers/directors;
- formal professional authority under the MSA.
What is not established:
- exact current shareholder roster;
- exact historical share percentages;
- exact CFMG stock-transfer terms;
- who can compel transfer or replacement of physician ownership.
Broad management authority#
The same agreement creates an extensive exclusive management system touching:
- accounting and finance;
- payroll administration and benefits;
- HR support and recruiting;
- physician employment forms;
- compensation administration;
- information systems;
- billing, coding, collections;
- records infrastructure;
- County contracting support;
- insurance and risk;
- legal and regulatory support;
- purchasing and operations.
the investigation therefore rejects a simplistic clinical-vs-administrative binary. Enterprise clinical/quality functions later make that boundary even more complex.
A. Core defense narrative#
CFMG is a California professional medical corporation that remained legally distinct from Wellpath and formally employed physicians. Wellpath and predecessor management entities supplied the extensive administrative infrastructure that allows a statewide correctional medical practice to function: payroll, benefits, HR support, information technology, credentialing administration, contracting support, insurance/risk, claims, litigation support, purchasing, finance, and related services.
The 2012 Management Services Agreement was deliberately structured to reserve professional medical services and physician judgment to CFMG while prohibiting the manager from practicing medicine or directly assuming patient-care responsibility. The management company was not pretending to be a hospital or a medical group. It was an MSO.
The fact that administrative functions became highly centralized after the 2018 Wellpath merger does not convert the MSO into the medical corporation.
The best direct evidence for that proposition includes:
- CFMG's continued separate legal existence;
- post-bankruptcy stipulations and orders treating CFMG as separate from Wellpath;
- quarterly DE 9 and DE 9C wage reports identifying the reporting entity, which would establish the same proposition from a public filing — not located in the public record for this project;
- sworn testimony that CFMG pays its employees;
- the Fresno County contract structure;
- contemporaneous professional-employment decision records showing which entity exercised the authority — not located in the public record for this project;
- and the unresolved public question of how CFMG physician-governance bodies are constituted, delegated, and documented in practice.
The defense therefore says:
the investigation has proved administrative integration, not unlawful displacement of physician authority.
IV. Contrary Evidence, Limits, and Competing Explanations#
A disciplined analysis must begin its limiting case with the strongest contrary evidence: Counterevidence to any simple narrative includes CFMG's continued legal existence, the distinction between enterprise transactions and PC shares, and the fact that later branding can obscure rather than replace juridical identity.
Why the name collision matters to the H.I.G. history#
H.I.G.'s January 7, 2013 press release said an H.I.G. affiliate made a "strategic investment in California Forensic Medical Group, Inc."
That public description is broad corporate shorthand.
It does not itself identify:
- which legal entity's stock was purchased;
- whether professional-corporation stock changed hands;
- what contractual rights accompanied the investment;
- whether investment occurred through a holding company or management entity.
The 2018 financing record is more technically specific.
It refers to acquisition of the capital stock of CFMG Holdings Corp.
Because the Wellpath bankruptcy later identifies Wellpath CFMG, Inc. as formerly CFMG Holdings Corp., the better working hypothesis is:
H.I.G.'s economic investment in the "CFMG" enterprise appears to have involved a holding/management-side corporate structure distinct from the California professional corporation itself.
That is still a hypothesis requiring the acquisition documents and pre-2018 organization chart for complete confirmation.
It should replace loose public phrasing such as:
"H.I.G. bought the California medical corporation."
The evidence assembled to date does not justify that statement.
V. Missing Documents and Falsification Tests#
The record remains incomplete in material respects. Key unresolved points include exact corporate succession, historical ownership, and whether later enterprise changes altered only management or also professional-corporation governance.
Why the 2012 management agreement matters#
The most revealing public document is CFMG’s December 31, 2012 Management Services Agreement, filed as an exhibit in Wellpath’s bankruptcy.
The agreement expressly says CFMG is a California professional corporation engaged in professional medical services. It describes CFMG and the management company as independent contractors and states that CFMG is solely and exclusively in control of professional medical services. At the same time, it makes the management company the exclusive provider of defined management services and assigns it extensive administrative responsibilities. Source: CFMG Management Services Agreement
That document is not a smoking gun for either side.
It is evidence of a deliberately layered system.
The formal model is:
CFMG — professional medical corporation
Management company / later Wellpath LLC — administrative and management infrastructure
The investigative question is whether actual operations followed the formal allocation when a matter reached a decision California reserves to physicians.
2013: H.I.G. announces an investment#
On January 7, 2013, H.I.G. Capital announced that an affiliate had made a strategic investment in CFMG. H.I.G. described the transaction as a partnership with CFMG’s existing management team. H.I.G., 2013
The wording is important.
The public announcement supports an investment relationship. It does not, without the underlying stock records, establish exactly what entity H.I.G. acquired or whether a non-physician investor ever held CFMG professional-corporation shares.
That distinction should remain explicit throughout this investigation.
Layer eight: medical records and information systems#
The manager’s role includes information technology, databases, connectivity, electronic medical-record implementation and maintenance, and supervision of record-maintenance infrastructure.
Those provisions establish broad technical and administrative access.
They do not establish that the manager could determine the substantive contents of a physician’s medical record.
That distinction matters because the Medical Board of California treats control of medical records as a professional-control issue.
For later investigation, every records question should be divided into:
- system ownership;
- technical administration;
- custodial responsibility;
- access control;
- content control;
- clinical amendment authority;
- disclosure authority.
A single word — “records” — is too imprecise.
Physician executive succession#
2019–2021. Herr remains central. By September 2021 a Monterey instrument identifies Herr as CFMG President and Judd Bazzel as Treasurer.
By September 2022. Public County agreements show Bazzel as CFMG President and Richard Medrano as Vice President/Secretary. The exact board/shareholder action producing this transition remains missing. No stock transfer should be inferred from officer succession.
By 2025. Corporate records identify Bazzel, Medrano, and Scott Kennedy as CFMG directors/officers. Their shareholder status remains unproved.
Right-to-Leave#
CFMG has real termination rights for qualifying breach and specified insolvency events. It is therefore inaccurate to say CFMG had “no right to leave.” The practical question is whether it could replace Wellpath while remaining economically, operationally, and professionally viable given long duration, renewal, management systems, financing, claims/insurance, HR/payroll, IT/EHR, records, County obligations, and the still-missing ownership/succession instruments.
This produces the controlling question:
Could CFMG replace Wellpath as manager without losing the ability to function as the County-contracted professional corporation?
MBC / OMBC / BRN#
The structural-control question#
The core structural question is not whether Wellpath legally owned CFMG.
The strongest currently available evidence cuts against that simplistic proposition.
In November 2024, Wellpath board co-chair Kip Hallman publicly stated that CFMG was a wholly separate entity, owned primarily by physicians, with no ownership overlap with Wellpath. Santa Barbara County later described CFMG as a separate physician-owned entity that used Wellpath to manage business aspects. CFMG remained a nondebtor professional corporation during the Wellpath Chapter 11 case.
Those facts are material.
But ownership of stock is only one form of control.
California's 2026 enforcement posture requires examination of whether a nonprofessional enterprise can exercise control through:
- contractual replacement rights;
- shareholder succession mechanisms;
- long-term exclusive management arrangements;
- financing;
- security interests;
- bank-account authority;
- control of assets or infrastructure;
- assignment rights;
- practical inability of the physician corporation to replace the manager.
The central the prior analysis inquiry therefore is:
Could CFMG physician owners independently reject, replace, or terminate Wellpath and continue operating a viable California medical corporation?
CFMG Shareholders, Directors, Officers, Company Designees, Stock Succession, Cross-Roles, and the Search for the Missing Stock-Transfer Agreements#
the prior analysis establishes why ownership succession is the top unresolved structural issue.
the prior analysis should reconstruct:
- every identifiable CFMG shareholder;
- every president/CEO/secretary/CFO;
- every Company Designee;
- overlap with CMGC/Wellpath roles;
- corporate signature history;
- death/resignation/retirement succession events;
- public filings and county contracts;
- historical H.I.G./CMGC transaction representations;
- the most likely repositories for the missing stock agreements.
Only after that chain is reconstructed should the investigation draw any conclusion about who ultimately controlled CFMG ownership.
The central refinement to the H.I.G. narrative#
the record should now change its phrasing.
Older shorthand:
"H.I.G. acquired CFMG."
Better:
H.I.G. publicly announced a strategic investment in the CFMG enterprise in January 2013. Later financing records identify CFMG Holdings Corp. as a stock-acquisition target, and that holding entity later appears in Wellpath's bankruptcy as Wellpath CFMG, Inc. f/k/a CFMG Holdings Corp. The available evidence does not establish that H.I.G. directly acquired the stock of California Forensic Medical Group, Incorporated, the California professional corporation.
That formulation is both more precise and more important.
It helps separate private-equity ownership of the management/holding enterprise from professional-corporation ownership.
THE 2025 RESTRUCTURING changed OWNERSHIP OF THE MANAGEMENT ENTERPRISE — not PROVEN CFMG STOCK OWNERSHIP#
Wellpath announced that it emerged from Chapter 11 in May 2025 and transitioned ownership to a group of its current and former lenders.
Primary Wellpath announcement:
https://wellpathcare.com/2025/05/12/wellpath-emerges-from-chapter-11-to-lead-a-new-era-in-correctional-healthcare/
Prospect Capital SEC filings independently confirm that its prepetition Wellpath debt was restructured on May 9, 2025 into new debt and equity positions in New WPCC Parent, LLC, plus an interest in the Wellpath Liquidating Trust.
Primary SEC record:
https://www.sec.gov/Archives/edgar/data/1287032/000128703226000164/psec-20260331.htm
Those records are important because they independently confirm the lender-to-equity restructuring.
They do not establish that New WPCC Parent acquired CFMG professional-corporation stock.
The entity distinction developed in the prior analysis remains critical:
New WPCC Parent / reorganized Wellpath enterprise ≠ automatically California Forensic Medical Group, Incorporated.
Any transfer of CFMG physician shares must be proved independently.
K. Ownership and succession remain the most important unresolved structural issue#
the prior analysis established that the 2019 assignment transferred the CFMG MSA together with related instruments expressly including relevant stock-transfer restriction agreements.
The enterprise bankruptcy record independently described Wellpath’s friendly-PC model as using stock-transfer agreements to manage ownership succession and qualification.
But the CFMG-specific operative instrument has not been authenticated in the current record.
Accordingly, the investigation cannot responsibly state whether Wellpath held:
- owner nomination rights;
- approval rights;
- veto rights;
- replacement rights;
- stock options;
- proxies;
- powers of attorney;
- mandatory-transfer rights;
- rights triggered by physician employment;
- or rights tied to MSA termination.
This missing instrument is especially important after California’s 2026 enforcement focus on physician-owner replacement and MSO entrenchment.
The correct final classification is:
TIER-ONE OPEN STRUCTURAL EVIDENCE — potentially decisive, not yet proved.
VI. Why the Issue Matters#
The stakes are practical rather than semantic. Counties need to know which entity is accountable for contracted performance; clinicians need to know where professional authority resides; courts and regulators need entity-specific evidence rather than brand shorthand; and the public needs a record that distinguishes corporate continuity from operational integration. Those distinctions become most important when the actors disagree, when a contract changes hands, when a professional decision conflicts with an economic preference, or when litigation requires a precise answer to who had authority to act.
CFMG predates Wellpath by decades#
H.I.G. Capital’s January 2013 announcement described CFMG as a California correctional-healthcare company founded in 1983 and operating across the state. H.I.G. announced that an affiliate had made a strategic investment in the company. The release identified CFMG’s then-president and medical director, Dr. Taylor Fithian, and described the company as a provider of outsourced healthcare to county jails. Source: H.I.G. Capital, Jan. 7, 2013
That announcement is important, but it should be read narrowly. It establishes an investment relationship. It does not, by itself, establish that H.I.G. directly acquired the shares of the California professional corporation or identify CFMG’s shareholder structure after the transaction.
California’s PC–MSO Boundary: What the Law Actually Protects#
California does not prohibit physicians from using management companies. It does prohibit unlicensed persons and ordinary corporations from taking over professional medical authority. The hard question is where administration ends and professional control begins.
That distinction is central to understanding CFMG and Wellpath.
A management-services organization can perform extensive business functions for a medical practice. Payroll, technology, accounting, benefits, contracting support, facilities and administrative staff do not become the practice of medicine simply because a non-physician organization handles them.
But California’s rule is not limited to bedside diagnosis.
The state’s own Medical Board identifies several “business” decisions as potentially constituting control over medical practice when they determine how physicians practice.
That makes the CFMG–Wellpath investigation a question of decision rights, not merely corporate ownership or branding.
VII. Falsification Tests and Evidentiary Limits Note#
The record does not support be read as establishing an unproven motive, an undisclosed shareholder, an unlawful medical override, or a legal conclusion that a court or regulator has not made. The strongest version of the thesis is the one that survives the missing-document test: identify the instrument, minutes, ledger, delegation, approval record, or disagreement event that would materially change the conclusion, then state what has and has not been found. If later primary evidence contradicts a proposition stated here, the correction should be made at the proposition level rather than defended through branding or organizational shorthand.
VIII. Related Articles#
- [Article 002](/research/cfmg-wellpath-california/articles/002-december-31-2012-the-agreement-that-rebuilt/) — December 31, 2012: The Agreement That Rebuilt CFMG Around an MSO
- [Article 004](/research/cfmg-wellpath-california/articles/004-the-2018-correct-care-cmgc-combination-enterprise/) — The 2018 Correct Care–CMGC Combination: Enterprise Merger Without CFMG Disappearing
- [Article 001](/research/cfmg-wellpath-california/articles/001-cfmg-before-wellpath-the-california-correctional-health/) — CFMG Before Wellpath: The California Correctional-Health Corporation That Predated the Brand
Linked sources#
The hyperlinked references in the text above, gathered for convenience. This is not the article’s citation list. Most of the record is cited in the prose itself — case names, docket numbers, courts, filing dates, agency records and contract identifiers — and those citations are not repeated here.
- 2019 Assignmentwww.prisonlegalnews.org
- CFMG Management Services Agreementwww.prisonlegalnews.org
- H.I.G., 2013hig.com
IX. The 2013 H.I.G. announcement is transaction evidence, not a cap table#
The January 7, 2013 H.I.G. Capital announcement is one of the earliest public documents tying institutional private equity to the CFMG enterprise. It states that an H.I.G. affiliate made a "strategic investment" in California Forensic Medical Group, Inc. and that H.I.G. partnered with CFMG's existing leadership. The release identifies Dr. Taylor Fithian as President and Medical Director and names senior operational and finance executives.
That language proves several important facts. H.I.G. publicly associated itself with an investment in the CFMG business. CFMG already existed as a substantial California correctional-health company. The investment was described as a partnership with incumbent management. Private equity entered the enterprise years before the Wellpath brand existed.
The same language does not answer the most legally important ownership question. A press release saying an affiliate made a strategic investment in "CFMG" may use the business name to describe an enterprise transaction. It does not identify which securities were acquired, whether the investment was made directly into the California professional corporation, whether a management entity or holding company received the capital, or whether physician shares changed hands. Those questions require transaction documents or corporate records.
A evidence-first analysis must resist the instinct to convert a transaction announcement into a stock ledger.
X. Timing makes the 2012 MSA the indispensable companion document#
The management services agreement was executed on December 31, 2012, days before the January 2013 H.I.G. announcement. That sequence is analytically important because it suggests that the professional-corporation/MSO architecture was formalized at the threshold of the investment era.
The MSA separates CFMG as the professional "Company" from a management entity. It reserves professional medical authority to CFMG while granting broad administrative responsibilities to the manager. The agreement therefore provides a plausible legal architecture through which outside capital and management expertise could participate economically in the business without directly owning or practicing medicine through the professional corporation.
That is the strongest lawful interpretation of the timing. It should be stated clearly.
The competing interpretation is that the MSA may have created a structure in which formal professional reservations coexisted with extensive practical management leverage. Whether that leverage crossed California's professional boundary cannot be answered from timing alone. The decisive documents are ownership, succession, termination, and conflict records.
XI. Three transaction layers should never be merged#
The 2013 history becomes much clearer when the transaction is separated into three possible layers.
Layer one — professional-corporation equity. Who owned the shares of California Forensic Medical Group, Inc.? California professional-corporation law makes this the most sensitive layer.
Layer two — management-company equity. Who owned the company providing administrative services to CFMG? Outside investors can have far broader ownership latitude in the management entity than in the professional corporation.
Layer three — enterprise economics. Who held debt, preferred interests, contractual fees, security interests, or other economic rights in the combined business platform?
A private equity investment can be economically transformative at layers two and three without transferring layer-one physician shares. Conversely, even if physician equity remains legally compliant, contractual rights at layers two and three can still create practical leverage relevant to professional independence.
The H.I.G. announcement does not tell us which combination occurred. It establishes the investment relationship and directs the investigation toward the missing transaction documents.
XII. The 2018 combination demonstrates why enterprise ownership and PC ownership diverge#
Five years later, H.I.G. announced the acquisition of Correct Care Solutions and its combination with existing portfolio company Correctional Medical Group Companies. The 2018 release described a combined company with roughly $1.5 billion in annual revenue, 15,000 employees, and operations across hundreds of facilities. That is unmistakable evidence of enterprise consolidation.
What happened next is equally important. The Wellpath brand emerged, but CFMG continued to appear in county contracts, labor records, litigation, and later bankruptcy-related filings as a distinct professional corporation. The January 2019 assignment of the CFMG MSA named CFMG as the Company and Wellpath LLC as the incoming Manager. That document is difficult to reconcile with a theory that the 2018 transaction simply merged CFMG out of existence.
The more defensible chronology is: private equity invested in the broader CFMG/management enterprise; the enterprise later combined with Correct Care Solutions; Wellpath became the national operating brand and management platform; CFMG continued as the California professional corporation.
That chronology still leaves the share-ownership question open.
XIII. Officer continuity is evidence of governance, not ownership by itself#
The public record identifies physician executives across the period: Taylor Fithian, later Raymond Herr, later Judd Bazzel, among others. Officer signatures on contracts are important evidence that CFMG maintained a functioning corporate identity with physician leadership. But corporate office is not the same as equity ownership.
A president can own all shares, some shares, or no shares. A medical director can be an officer without being a shareholder. A shareholder can exercise ownership rights without holding the most visible executive title. Therefore, officer succession should be reconstructed separately from shareholder succession.
The missing evidence is board and shareholder minutes, stock ledgers, stock certificates, transfer documents, and beneficial-ownership records. Those sources can show whether physician ownership persisted across the H.I.G. investment and later enterprise transitions.
XIV. The Company Designee provision is a control clue that requires an appointment record#
The MSA's concept of a Company Designee is significant because it appears to create a channel through which CFMG exercises rights under the management relationship. The actual identity, authority, and appointment of that designee can reveal whether CFMG retained an institutional voice distinct from the manager.
If the designee was independently appointed by CFMG's physician governance and could direct or reject management conduct within reserved domains, that would support meaningful autonomy. If the designee was selected or removable by management, or if the role existed only on paper, the inference would differ.
The analysis therefore must treat the designee records as a Tier-One target rather than infer authority from the contract label alone.
XV. The 2025 restructuring illustrates the same ownership distinction in modern form#
Wellpath's May 2025 emergence announcement states that ownership of the reorganized company transitioned to a group of current and former lenders. That is a clear ownership change at the management-enterprise level.
It does not establish that those lenders acquired CFMG's professional-corporation shares. Post-bankruptcy California litigation reinforces the distinction by describing CFMG as a separate, nondebtor professional corporation. Current county and labor records continue to identify CFMG after emergence.
The 2013 and 2025 events therefore bookend the same methodological problem. "Investment in CFMG" and "ownership of Wellpath" can describe enterprise economics without resolving professional-corporation equity. The exact security and entity matter.
XVI. The Attorney General's 2026 enforcement position raises the value of the missing 2013 transaction documents#
California's 2026 Carbon Health enforcement action focused not simply on who nominally held medical-practice shares, but on whether the MSO could replace the physician owner and whether the physician could replace the MSO without jeopardizing ownership. That enforcement theory makes historical transfer and succession rights more significant.
If the H.I.G. investment was structured through a management company while CFMG physician ownership remained independent and freely transferable among qualified physicians, the transaction could fit a conventional lawful PC-MSO model. If the investment documents gave nonphysician investors or the manager effective power to designate the physician owner or compel share transfer, the analysis would be different.
No public evidence reviewed here establishes those CFMG-specific terms. The correct conclusion is not that they were lawful or unlawful; it is that they are now the most important missing part of the 2013 story.
XVII. The economic-control question should be tested separately from equity#
Private equity can exercise influence through debt, board rights in management entities, covenants, budgets, incentive compensation, security interests, and contractual fees without owning professional-corporation shares. Those mechanisms can matter to how a healthcare enterprise operates.
Economic leverage becomes relevant to corporate-practice analysis only when it affects physician-reserved professional decisions. A lender covenant requiring financial reporting is not the practice of medicine. A management fee tied to revenue is not automatically unlawful. A budget constraint can influence operations without dictating treatment. The critical evidence is the bridge from economic rights to professional decisions.
That bridge could be shown by contemporaneous records: an investor directive changing clinical staffing against physician objection, a financial veto over medically necessary referrals, a succession right affecting professional ownership, or a binding policy imposed without physician approval. Without that bridge, the investment remains context rather than proof of improper control.
XVIII. The strongest lawful 2013 narrative#
The strongest lawful narrative is that H.I.G. invested in the business and management infrastructure surrounding CFMG while the California professional corporation remained appropriately physician-owned and retained professional authority under the MSA. Outside capital funded growth, systems, recruiting, contracting, and administration. Physician leadership continued to control clinical practice. The later 2018 combination and Wellpath rebranding changed the management enterprise but not the core legal requirement that CFMG remain a professional corporation.
This narrative is consistent with CFMG's continued existence, the MSA's express professional reservations, later county contracts, physician officers, and post-bankruptcy separateness.
XIX. The strongest practical-control narrative#
The competing narrative is that the 2012-2013 restructuring may have transferred substantial practical control to outside capital through management rights, financing, succession instruments, and enterprise infrastructure while preserving formal physician ownership. Under this theory, the relevant question is not whether H.I.G. directly held CFMG stock but whether the investment architecture constrained who could own the practice, who could replace the manager, and who prevailed in professional conflicts.
The public record supports investigation of that possibility because the MSA is broad and related stock-transfer instruments are referenced. It does not prove the hypothesis.
XX. What the 2013 transaction file should contain#
A complete transaction reconstruction should seek:
- purchase or investment agreement;
- disclosure schedules;
- capitalization table before and after closing;
- CFMG shareholder ledger;
- management-company equity records;
- board and shareholder approvals;
- financing documents;
- security agreements;
- stock-transfer restrictions;
- option, proxy, escrow, or power-of-attorney instruments;
- employment and retention agreements for physician leadership;
- management-fee amendments;
- governance side letters;
- closing binders identifying each acquired entity; and
- any legal opinion addressing California professional-corporation compliance.
Those documents would identify what H.I.G. actually purchased and what it did not.
XXI. Falsification#
A theory of direct nonphysician CFMG ownership would be falsified by authenticated records showing that eligible physicians continuously held all required professional shares and that H.I.G.'s investment sat entirely in management or holding entities. A theory of complete professional independence would be weakened if the transaction documents show investor-controlled succession, mandatory share transfer, or other rights that materially constrain physician ownership or professional governance.
This analysis is designed to accept either result.
Finding#
The 2013 H.I.G. investment is a major event in the CFMG story because it marks the point at which private equity became publicly associated with the enterprise that later evolved into Wellpath. The evidence proves investment, partnership with management, and the beginning of a more complex enterprise structure. It does not prove the identity of CFMG's shareholders.
The correct historical conclusion is that H.I.G.'s 2013 strategic investment changed the economic and management context around CFMG, while the public record does not establish that the investment directly transferred California professional-corporation stock. The 2012 MSA provides a lawful structural explanation for outside management and capital; the missing shareholder and stock-transfer records determine whether that structure also preserved meaningful physician ownership and exit rights in practice.
Additional authorities#
- H.I.G. Capital, H.I.G. Capital Announces Strategic Investment in California Forensic Medical Group, Jan. 7, 2013.
- 2012 CFMG Management Services Agreement.
- H.I.G. Capital, Correct Care Solutions and Correctional Medical Group Companies Join Forces, Oct. 1, 2018.
- 2019 Assignment of Management Services Agreement to Wellpath LLC.
- Wellpath emergence announcement, May 12, 2025.
- Medical Board of California corporate-practice guidance and California Attorney General 2026 CPOM enforcement materials.
XXIII. The analysis must distinguish investment control from medical control#
An investor can influence strategy, capital allocation, acquisitions, executive hiring, growth targets, and financial reporting without practicing medicine. Those are ordinary incidents of investment. The corporate-practice question arises only when the rights extend into physician-reserved professional judgment or the ownership of the professional corporation in a prohibited way.
That distinction should be explicit because private equity itself is not the legal violation under investigation. The relevant evidence is the contractual bridge between capital and professional authority.
XXIV. The historical sequence supports continuity of the PC even as the enterprise changed around it#
CFMG predates H.I.G. by decades. The 2012 MSA created the management architecture. H.I.G. announced its investment in January 2013. Correct Care Solutions and CMGC combined in 2018. Wellpath LLC became the manager in 2019. Wellpath entered Chapter 11 in 2024 and emerged under lender ownership in 2025. CFMG continues to appear in public California records afterward.
That sequence is strong evidence that CFMG's juridical identity persisted through multiple changes in enterprise ownership and branding. It does not by itself prove uninterrupted shareholder continuity, but it makes a simple merger-disappearance narrative difficult to sustain.
Findings by confidence#
Very high confidence: H.I.G. publicly announced a strategic investment in the CFMG business in January 2013.
Very high confidence: the 2012 management agreement preceded that announcement and separated the professional corporation from a management organization.
High confidence: the 2018 combination and 2019 assignment changed the broader management enterprise while CFMG continued as the California professional corporation.
Not established: the exact CFMG share ownership immediately before and after the 2013 investment or the terms of the CFMG-specific succession instrument.
XXVII. Source weighting for the 2013 transaction#
The H.I.G. press release is a first-party transaction announcement and therefore strong evidence that H.I.G. publicly described an investment in CFMG. The MSA is an executed contract and stronger on allocation of management rights. County contracts and later litigation are stronger on CFMG's continued juridical existence. None is a substitute for the missing capitalization and stock-transfer records.
This hierarchy should be explicit so readers understand why the article accepts the investment announcement while declining to infer direct professional-corporation ownership.
XXVIII. The 2013 transaction should be coded as an enterprise event with an open equity subquestion#
For the project timeline, the safest classification is: enterprise investment established; professional-corporation equity treatment unresolved. That code can remain stable even if later stock records appear. New evidence would resolve the equity subquestion without requiring the entire historical chronology to be rewritten.
XXIX. Final historical note#
The most significant lesson from 2013 is methodological. Corporate history is easiest to distort when a familiar modern brand is projected backward. Wellpath did not yet exist as the public brand. CFMG did. The transaction should be described using the entities and documents that existed at the time, then connected forward through the 2018 combination and 2019 assignment. That chronology is more accurate than treating the modern enterprise as though it had always been organized in its current form.
XXX. The investment chronology should be preserved as a series of legally distinct transactions#
The 2013 investment, 2018 combination, 2019 MSA assignment, 2024 bankruptcy filing, and 2025 emergence are not one continuous merger event. Each has its own documents, counterparties, and legal effect. The analysis therefore must resist compressed phrases such as "H.I.G. bought CFMG and turned it into Wellpath" unless every link in that proposition is separately proven.
A more accurate history is granular: H.I.G. announced an investment in the CFMG business; H.I.G. later combined Correct Care Solutions with CMGC; the management role under CFMG's agreement moved to Wellpath LLC; the management enterprise later restructured in Chapter 11; CFMG continued to appear as a distinct California professional corporation. That sequence is both more cautious and more informative.
XXXI. The analysis must separate what H.I.G. said from what later records prove#
H.I.G.'s 2013 announcement is authoritative for H.I.G.'s own description of the transaction. Later contracts, assignments, and litigation can corroborate continuity or clarify entity structure, but they should not be written as though they retroactively changed the wording of the 2013 deal. The analysis must quote or paraphrase the announcement narrowly, then use later primary documents to test what survived.
That source separation prevents hindsight from turning a public relations description into a legal conclusion it never purported to make.
Linked sources#
The hyperlinked references in the text above, gathered for convenience. This is not the article’s citation list. Most of the record is cited in the prose itself — case names, docket numbers, courts, filing dates, agency records and contract identifiers — and those citations are not repeated here.
- 2019 Assignmentwww.prisonlegalnews.org
- CFMG Management Services Agreementwww.prisonlegalnews.org
- H.I.G., 2013hig.com